Acm Research stock hits 52-week high at 32.5 USD

Published 30/07/2025, 14:48
Acm Research stock hits 52-week high at 32.5 USD

Acm Research Inc. (ACMR) stock has reached a 52-week high, climbing to 32.5 USD. This milestone reflects a significant upward trend for the semiconductor equipment manufacturer, with a market capitalization of $2.07 billion and an attractive P/E ratio of 18.7. According to InvestingPro analysis, ACMR is currently trading below its Fair Value, suggesting potential upside opportunity. Over the past year, ACMR has experienced a substantial 78.22% increase in its stock price, with an even more impressive year-to-date return of 109.8%. The company’s recent achievements and strategic initiatives appear to be resonating well with investors, demonstrated by its 26.2% revenue growth and "GREAT" Financial Health Score. InvestingPro subscribers have access to 12 additional investment tips and a comprehensive Pro Research Report for ACMR, offering deeper insights into the company’s potential.

In other recent news, ACM Research (NASDAQ:ACMR) reported its financial results for the first quarter of 2025, surpassing analysts’ expectations. The company achieved an earnings per share (EPS) of $0.46, exceeding the forecast of $0.3186, and reported revenue of $172.3 million, which was above the expected $170.25 million. Additionally, ACM Research’s management has maintained its full-year 2025 revenue guidance of $850-950 million. The company anticipates that its Track and Plasma Enhanced Chemical Vapor Deposition (PECVD) products will start contributing to revenue by the end of 2025, with a more significant impact expected in 2026.

Benchmark has reiterated a Buy rating on ACM Research, with a price target of $38.00, following discussions about the company’s serviceable addressable market and long-term business model. In contrast, Jefferies revised its price target for ACM Research shares to $30.00 from $34.00, while maintaining a Buy rating. Jefferies noted that ACM Research’s first-quarter earnings exceeded expectations, with EBIT and net profit surpassing forecasts by 44%. These developments highlight ACM Research’s operational performance and strategic outlook.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.